CICLOPIROX

NDC 0574-2061 · Padagis US LLC

Generic nameCICLOPIROX

Dosage formGEL

RouteTOPICAL

Active ingredient(s)CICLOPIROX

Strength7.7 mg/g

Pharmacologic classDecreased DNA Replication [PE], Decreased Protein Synthesis [PE], Decreased RNA Replication [PE], Protein Synthesis Inhibitors [MoA]

Marketing categoryANDA

Packages

0574-2061-01 — 1 TUBE in 1 CARTON (0574-2061-01) / 100 g in 1 TUBE

0574-2061-30 — 1 TUBE in 1 CARTON (0574-2061-30) / 30 g in 1 TUBE

0574-2061-45 — 1 TUBE in 1 CARTON (0574-2061-45) / 45 g in 1 TUBE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0591-2159 — Ciclopirox, 21922-053 — ciclopirox, 21922-105 — ciclopirox, 42192-715 — Ciclopirox, 45802-141 — Ciclopirox, 45802-401 — Ciclopirox, 50090-6562 — Ciclopirox, 51672-1351 — ciclopirox, 62135-814 — Ciclopirox, 63629-8620 — CICLOPIROX, 63629-8621 — CICLOPIROX, 63629-8622 — CICLOPIROX, 63629-8623 — Ciclopirox, 68462-455 — ciclopirox, 68788-6797 — Ciclopirox, 68788-8755 — ciclopirox, 71335-2757 — ciclopirox, 71335-2836 — ciclopirox, 72162-1126 — CICLOPIROX, 72162-1321 — Ciclopirox, +2 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.